Tetsuya Matoba

7.2k total citations · 2 hit papers
122 papers, 5.1k citations indexed

About

Tetsuya Matoba is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Tetsuya Matoba has authored 122 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Cardiology and Cardiovascular Medicine, 33 papers in Surgery and 27 papers in Molecular Biology. Recurrent topics in Tetsuya Matoba's work include Coronary Interventions and Diagnostics (17 papers), Antiplatelet Therapy and Cardiovascular Diseases (16 papers) and Atrial Fibrillation Management and Outcomes (15 papers). Tetsuya Matoba is often cited by papers focused on Coronary Interventions and Diagnostics (17 papers), Antiplatelet Therapy and Cardiovascular Diseases (16 papers) and Atrial Fibrillation Management and Outcomes (15 papers). Tetsuya Matoba collaborates with scholars based in Japan, United States and United Kingdom. Tetsuya Matoba's co-authors include Kensuke Egashira, Hiroaki Shimokawa, Akira Takeshita, Kaku Nakano, Yasushi Mukai, Jun‐ichiro Koga, Kenji Sunagawa, Yoji Hirakawa, Keiko Morikawa and Bradford C. Berk and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Investigation.

In The Last Decade

Tetsuya Matoba

108 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice

2000 598 citations Tetsuya Matoba, Hiroaki Shimokawa et al. Journal of Clinical Investigation profile →
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease

2019 297 citations Satoshi Yasuda, Koichi Kaikita et al. profile →

Peers

Countries citing papers authored by Tetsuya Matoba

Since Specialization

Citations

This map shows the geographic impact of Tetsuya Matoba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuya Matoba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuya Matoba more than expected).

Fields of papers citing papers by Tetsuya Matoba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuya Matoba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuya Matoba. The network helps show where Tetsuya Matoba may publish in the future.

Co-authorship network of co-authors of Tetsuya Matoba

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuya Matoba. A scholar is included among the top collaborators of Tetsuya Matoba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuya Matoba. Tetsuya Matoba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Drp1-mediated mitochondrial fission protects macrophages from mtDNA/ZBP1-mediated inflammation and inhibits post-infarct cardiac remodelling 2026 ·Cardiovascular Research ·(unknown), (unknown), (unknown), Lixiang Wang, Nao Hasuzawa, (unknown), Tetsuya Matoba, (unknown), (unknown), (unknown)	0
2	Medication Adherence and Antithrombotic Therapy Outcomes 2026 ·JACC Asia ·(unknown), Takashi Noda, (unknown), (unknown), (unknown), (unknown), Tetsuya Matoba, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
3	Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation 2024 ·Diabetologia ·Muneo Yamaguchi, Shintaro Nakao, Mitsuru Arima, Karis Little, (unknown), Iori Wada, Yoshihiro Kaizu, Souska Zandi, Justus G. Garweg, Tetsuya Matoba, (unknown), (unknown), Kensuke Shibata, Yasuhiro Go, Tatsuro Ishibashi, Akiyoshi Uemura, Alan W. Stitt, Koh‐Hei Sonoda	13
4	Clinical Deep Data Accumulation System (CLIDAS) reveals a "Lipid paradox" of hypertriglyceridemia in Japanese patients 2024 ·European Heart Journal ·Shunsuke Katsuki, Takuya Kawahara, (unknown), (unknown), (unknown), Tetsuya Matoba	0
5	A Vaccine Against Fibroblast Activation Protein Improves Murine Cardiac Fibrosis by Preventing the Accumulation of Myofibroblasts 2024 ·Circulation Research ·Shota Yoshida, Hiroki Hayashi, (unknown), Shunsuke Katsuki, (unknown), (unknown), Jiao Sun, Ryo Nakamaru, Akiko Tenma, (unknown), Satoshi Baba, Munehisa Shimamura, Tomohiro Katsuya, Ryuichi Morishita, Hiromi Rakugi, Tetsuya Matoba, Hironori Nakagami	5
6	Antithrombotic therapy for stable coronary artery disease and atrial fibrillation in patients with and without revascularisation: the AFIRE trial 2024 ·EuroIntervention ·Takashi Noda, Kotaro Nochioka, Koichi Kaikita, Masaharu Akao, Junya Ako, Tetsuya Matoba, Masato Nakamura, Katsumi Miyauchi, Nobuhisa Hagiwara, Kazuo Kimura, Atsushi Hirayama, Kunihiko Matsui, Hisao Ogawa, Satoshi Yasuda, (unknown)	2
7	Thrombocytopenia as a Bleeding Risk Factor in Atrial Fibrillation and Coronary Artery Disease: Insights From the AFIRE Study 2023 ·Journal of the American Heart Association ·Raisuke Iijima, (unknown), Masato Nakamura, Satoshi Yasuda, Koichi Kaikita, Masaharu Akao, Junya Ako, Tetsuya Matoba, Katsumi Miyauchi, Nobuhisa Hagiwara, Kazuo Kimura, Atsushi Hirayama, Kunihiko Matsui, Hisao Ogawa, (unknown)	3
8	Mapping of Purkinje‐related ventricular arrhythmias by a multispline catheter with small and close‐paired electrodes: Comparison with conventional catheters 2023 ·Pacing and Clinical Electrophysiology ·(unknown), Yasushi Mukai, Kazuhiro Nagaoka, (unknown), Shunsuke Kawai, (unknown), (unknown), Takeshi Tohyama, Shujiro Inoue, Kenji Sadamatsu, Hideki Tashiro, Kazuo Sakamoto, Tetsuya Matoba, Akiko Chishaki, Shintaro Kinugawa, Hiroyuki Tsutsui	0
9	Associations among cardiovascular and cerebrovascular diseases: Analysis of the nationwide claims-based JROAD-DPC dataset 2022 ·PLoS ONE ·Michikazu Nakai, Yoshitaka Iwanaga, Yoko Sumita, Shinichi Wada, (unknown), Koji Iihara, Takahide Kohro, Issei Komuro, Tomohiro Kuroda, Tetsuya Matoba, Masaaki Nakayama, Kunihiro Nishimura, Teruo Noguchi, (unknown), Teiji Tominaga, Ḱazunori Toyoda, Kenichi Tsujita, Satoshi Yasuda, Yoshihiro Miyamoto, Hisao Ogawa	19
10	Percutaneous coil embolization and stent implantation for multiple coronary-to-pulmonary artery fistulas with giant coronary aneurysms: a case report 2022 ·European Heart Journal - Case Reports ·(unknown), Tetsuya Matoba, (unknown), Hiroyuki Tsutsui	2
11	Clinical picture of the duration of venoarterial extracorporeal membrane oxygenation: analysis from JROAD-DPC 2022 ·Heart and Vessels ·Kazuo Sakamoto, Tetsuya Matoba, Michikazu Nakai, Yoshio Tahara, Takahiro Nakashima, Hayato Hosoda, Yoshihiro Miyamoto, Kunihiro Nishimura, Yoko Sumita, Tsukasa Yagi, Kenzo Ichimura, Naohiro Yonemoto, Eizo Tachibana, Ken Nagao, Takanori Ikeda, Naoki Sato, Hiroyuki Tsutsui	0
12	The association between the socioeconomic deprivation level and ischemic heart disease mortality in Japan: an analysis using municipality-specific data 2022 ·Epidemiology and Health ·Tasuku Okui, Tetsuya Matoba, Naoki Nakashima	2
13	Aspirin versus P2Y₁₂ inhibitors with anticoagulation therapy for atrial fibrillation 2021 ·Heart ·Hidehira Fukaya, Junya Ako, Satoshi Yasuda, Koichi Kaikita, Masaharu Akao, Tetsuya Matoba, (unknown), Katsumi Miyauchi, Nobuhisa Hagiwara, Kazuo Kimura, Atsushi Hirayama, Kunihiko Matsui, Hisao Ogawa	5
14	Nanoparticle‐Mediated Simultaneous Targeting of Mitochondrial Injury and Inflammation Attenuates Myocardial Ischemia‐Reperfusion Injury 2021 ·Journal of the American Heart Association ·Gentaro Ikeda, Tetsuya Matoba, Ayako Ishikita, Kazuhiro Nagaoka, Kaku Nakano, Jun‐ichiro Koga, Hiroyuki Tsutsui, Kensuke Egashira	35
15	Bleeding and Subsequent Cardiovascular Events and Death in Atrial Fibrillation With Stable Coronary Artery Disease: Insights From the AFIRE Trial 2021 ·Circulation Cardiovascular Interventions ·Koichi Kaikita, Satoshi Yasuda, Masaharu Akao, Junya Ako, Tetsuya Matoba, Masato Nakamura, Katsumi Miyauchi, Nobuhisa Hagiwara, Kazuo Kimura, Atsushi Hirayama, Kunihiko Matsui, Hisao Ogawa, (unknown)	23
16	Clinical characteristics and prognostic factors in acute coronary syndrome patients complicated with cardiogenic shock in Japan: analysis from the Japanese Circulation Society Cardiovascular Shock Registry 2019 ·Heart and Vessels ·Kazuo Sakamoto, Tetsuya Matoba, Masahiro Mohri, Yasushi Ueki, Yasuyuki Tsujita, Masao Yamasaki, Nobuhiro Tanaka, (unknown), Motoki Fukutomi, Katsutaka Hashiba, (unknown), Satoru Suwa, Hirohide Matsuura, Eizo Tachibana, Naohiro Yonemoto, Ken Nagao	13
17	Formulation of Nanoparticle-Eluting Stents by a Cationic Electrodeposition Coating Technology 2009 ·JACC: Cardiovascular Interventions ·Kaku Nakano, Kensuke Egashira, (unknown), Kouta Funakoshi, Gang Zhao, Satoshi Kimura, Tetsuya Matoba, Katsuo Sueishi, Yasuhisa Endo, Yoshiaki Kawashimà, Kaori Hara, Hiroyuki Tsujimoto, Ryuji Tominaga, Kenji Sunagawa	106
18	Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease 2005 ·Coronary Artery Disease ·Yoshihiro Fukumoto, Akira Itô, Toyokazu Uwatoku, Tetsuya Matoba, Takuya Kishi, Haruki Tanaka, Akira Takeshita, Kenji Sunagawa, Hiroaki Shimokawa	148
19	Pivotal role of Cu,Zn-superoxide dismutase in endothelium-dependent hyperpolarization 2003 ·Journal of Clinical Investigation ·Keiko Morikawa, Hiroaki Shimokawa, Tetsuya Matoba, Hitoshi Kubota, Takaaki Akaike, M.A. Hassan Talukder, Makoto Hatanaka, Takako Fujiki, Hiroshi Maeda, Shosuke Takahashi, Akira Takeshita	29
20	Hydrogen Peroxide Is an Endothelium-Derived Hyperpolarizing Factor in Animals and Humans 2003 ·SHILAP Revista de lepidopterología ·Tetsuya Matoba, Hiroaki Shimokawa	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact